Summary of treatment options GLP-1 and GIP drugs : Drugs such as tirzepatide (a dual agonist of the GIP and GLP-1 receptors) have shown significant efficacy in reducing body weight and improving glycaemic control in obese or overweight patients with type 2 diabetes
Digestive Changes That Raise Risk For Nerve-Related Deficiencies GLP-1 medications are known for changing appetite and slowing gastric emptying
These include feeling faint when standing up quickly (postural hypotension), persistent fatigue, confusion, or blurred vision
Szczch, J., Wiatrowski, A., Hirnle, L
Studies have already highlighted the efficiency of green tea in stimulating GLP-1
Neuropilin-1 mediates SARS-CoV-2 infection of astrocytes in brain organoids, inducing inflammation leading to dysfunction and death of neurons